Supraclavicular Versus Interscalene Block for Shoulder Surgery

Pain Clinical Trial

Official title:

A Prospective Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block in Patients Undergoing Arthroscopic Shoulder Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02486549
• Other study ID #: artroscopy
• Status: Completed
• Phase: N/A
• First received: June 24, 2015
• Last updated: February 20, 2017
• Start date: June 2015
• Est. completion date: February 2017

Study information

• Verified date: February 2017
• Source: Tokat Gaziosmanpasa University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare the supraclavicular block to interscalene block in patients undergoing arthroscopic shoulder surgery.

Description:

The aim of this study is to evaluate the efficacy of the supraclavicular block in comparison with interscalene block on postoperative pain, quality of recovery and side effects in patients undergoing arthroscopic shoulder surgery under general anesthesia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 62
• Est. completion date: February 2017
• Est. primary completion date: February 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients undergoing shoulder surgery in American Society of Anesthesiologists physical status I-II

Exclusion Criteria:

• with a known allergy to study medications,

• chronic opioid use,

• ipsilateral upper limb neurological deficits,

• severe respiratory disease,

• coagulopathy

Related Conditions & MeSH terms

• Pain

Intervention

Procedure:
• Supraclavicular Block
Under ultrasound guidance an insulated needle is advanced with in- plane technique into the brachial plexus sheath and 20ml 0.25% bupivacaine will be administered
• Interscalene Block
Under ultrasound guidance an insulated needle will be placed through the middle scalene muscle,into the interscalene groove with in-plane technique and 20ml 0.25%bupivacaine will be administered into the brachial plexus

Drug:
• Bupivacaine
20ml 0.25% bupivacaine will be injected for brachial plexus block

Device:
• Ultrasound
The Ultrasound will be used for brachial plexus visualization

Locations

Country	Name	City	State
Turkey	Gaziosmanpasa University Medical School	Tokat

Sponsors (1)

Lead Sponsor	Collaborator
Tokat Gaziosmanpasa University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative Pain	The visual analog scale will be used for assessment	up to postoperative 24 hours
Secondary	Quality of recovery	The Quality of Recovery-40 (QR40) questionnaire will be used for assessment	in the postoperative 24 hours
Secondary	Motor block	The muscle force will be evaluated with scale 0 to 3( 0:normal muscle force, 1: reduced muscle force, 2: impaired mobility 3: paralysis	up to postoperative 24 hours
Secondary	Sensory block	The sensorial block will be assessed by pinprick test.	up to postoperative 24 hours
Secondary	Adverse events	The number of patients with adverse events will be recorded.	up to postoperative 24 hours
Secondary	Analgesics requirement time	the first intravenous analgesic requirement time will be recorded.	up to postoperative 24 hours
Secondary	Systolic Blood pressure changes	The blood pressure will be measured non invasively and the systolic blood pressure lower than 90 mmHg or decrease more than 20% of baseline will be accepted as a hypotension.	at time of surgery
Secondary	Heart rate changes	The heart rate will be assessed via electrocardiographic monitoring and recorded as beat/minute.	at time of surgery